郵輪股新一年回落 挪威郵輪、皇家加勒比遭拋售挫逾7%
美股當中,郵輪業股票繼2023年創下創紀錄全年升幅後,於新一年首個交易日為標普500指數中表現最差的股票之一。
挪威郵輪(NCLH.US)下跌8%,於標普500指數中跌幅最大,跌至三星期低位。挪威郵輪在2023年飆升近64%。
標普 500 指數中表現第二差的是皇家加勒比集團股票(RCL.US)跌逾7%,料創自2022年9月30日以來最差單日表現。該股於2023年全年飆升162%,為1993年上市以來最好的一年。
嘉年華(CCL.US)跌逾6%,為標普500指數中表現第四差的股票。該股於2023年飆升131%,打破1991年創下的86%最高一年升幅紀錄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.